1
|
Homagk L, Marmelstein D, Homagk N and
Hofmann GO: SponDT (spondylodiscitis diagnosis and treatment):
Spondylodiscitis scoring system. J Orthop Surg Res.
14(100)2019.PubMed/NCBI View Article : Google Scholar
|
2
|
Zarghooni K, Röllinghoff M, Sobottke R and
Eysel P: Treatment of spondylodiscitis. Int Orthop. 36:405–411.
2012.PubMed/NCBI View Article : Google Scholar
|
3
|
Cebrián Parra JL, Saez-Arenillas Martín A,
Urda Martínez-Aedo AL, Soler Ivañez I, Agreda E and Lopez-Duran
Stern L: Management of infectious discitis. Outcome in one hundred
and eight patients in a university hospital. Int Orthop.
36:239–244. 2012.PubMed/NCBI View Article : Google Scholar
|
4
|
Gouliouris T, Aliyu SH and Brown NM:
Spondylodiscitis: Update on diagnosis and management. J Antimicrob
Chemother. 65 (Suppl 3):iii11–iii24. 2010.PubMed/NCBI View Article : Google Scholar
|
5
|
Rutges JPHJ, Kempen DH, van Dijk M and
Oner FC: Outcome of conservative and surgical treatment of pyogenic
spondylodiscitis: A systematic literature review. Eur Spine J.
25:983–999. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Guerado E and Cerván AM: Surgical
treatment of spondylodiscitis. An update. Int Orthop. 36:413–420.
2012.PubMed/NCBI View Article : Google Scholar
|
7
|
Garkowski A, Zajkowska A, Czupryna P,
Lebkowski W, Letmanowski M, Gołębicki P, Moniuszko A, Ustymowicz A,
Pancewicz S and Zajkowska J: Infectious spondylodiscitis-a case
series analysis. Adv Med Sci. 59:57–60. 2014.PubMed/NCBI View Article : Google Scholar
|
8
|
Cheung WY and Luk KDK: Pyogenic
spondylitis. Int Orthop. 36:397–404. 2012.PubMed/NCBI View Article : Google Scholar
|
9
|
Zimmerli W: Clinical practice. Vertebral
osteomyelitis. N Engl J Med. 362:1022–1029. 2010.PubMed/NCBI View Article : Google Scholar
|
10
|
Li YD, Wong CB, Tsai TT, Lai PL, Niu CC,
Chen LH and Fu TS: Appropriate duration of post-surgical
intravenous antibiotic therapy for pyogenic spondylodiscitis. BMC
Infect Dis. 18(468)2018.PubMed/NCBI View Article : Google Scholar
|
11
|
Berbari EF, Kanj SS, Kowalski TJ,
Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD,
Huddleston PM III, Petermann GW, et al: 2015 2015 Infectious
diseases society of America (IDSA) clinical practice guidelines for
the diagnosis and treatment of native vertebral osteomyelitis in
adults. Clin Infect Dis. 61:e26–e46. 2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Yee DKH, Samartzis D, Wong YW, Luk KDK and
Cheung KMC: Infective spondylitis in Southern Chinese: A
descriptive and comparative study of ninety-one cases. Spine (Phila
Pa 1976). 35:635–641. 2010.PubMed/NCBI View Article : Google Scholar
|
13
|
Ceccarelli M, Marino A, Pulvirenti S, Coco
V, Busà B, Nunnari G and Cacopardo BS: Bacterial and fungal
co-infections and superinfections in a cohort of COVID-19 patients:
Real-life data from an italian third level hospital. Infect Dis
Rep. 14:372–382. 2022.PubMed/NCBI View Article : Google Scholar
|
14
|
Bartoletti M, Pascale R, Cricca M, Rinaldi
M, Maccaro A, Bussini L, Fornaro G, Tonetti T, Pizzilli G,
Francalanci E, et al: Epidemiology of invasive pulmonary
aspergillosis among COVID-19 intubated patients: A prospective
study. Clin Infect Dis. (ciaa1065)2020.PubMed/NCBI View Article : Google Scholar
|
15
|
Scott H, Zahra A, Fernandes R, Fries BC,
Thode HC Jr and Singer AJ: Bacterial infections and death among
patients with Covid-19 versus non Covid-19 patients with pneumonia.
Am J Emerg Med. 51:1–5. 2022.PubMed/NCBI View Article : Google Scholar
|
16
|
Marino A, Campanella E, Stracquadanio S,
Ceccarelli M, Zagami A, Nunnari G and Cacopardo B: Corynebacterium
striatum bacteremia during SARS-CoV2 infection: Case Report,
Literature review, and clinical considerations. Infect Dis Rep.
14:383–390. 2022.PubMed/NCBI View Article : Google Scholar
|
17
|
Temperoni C, Caiazzo L and Barchiesi F:
High prevalence of antibiotic resistance among opportunistic
pathogens isolated from patients with COVID-19 under mechanical
ventilation: Results of a single-center study. Antibiotics (Basel).
10(1080)2021.PubMed/NCBI View Article : Google Scholar
|
18
|
Garcia-Vidal C, Sanjuan G, Moreno-García
E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Fernandez-Pittol
M, Pitart C, Inciarte A, Bodro M, et al: Incidence of co-infections
and superinfections in hospitalized patients with COVID-19: A
retrospective cohort study. Clin Microbiol Infec. 27:83–88.
2021.PubMed/NCBI View Article : Google Scholar
|
19
|
Habib G, Lancellotti P, Antunes MJ,
Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G,
Erba PA, Iung B, et al: 2015 ESC guidelines for the management of
infective endocarditis: The task force for the management of
infective endocarditis of the European society of cardiology (ESC).
Endorsed by: European association for cardio-thoracic surgery
(EACTS), the European association of nuclear medicine (EANM). Eur
Heart J. 36:3075–3128. 2015.PubMed/NCBI View Article : Google Scholar
|
20
|
Bhavan KP, Marschall J, Olsen MA, Fraser
VJ, Wright NM and Warren DK: The epidemiology of hematogenous
vertebral osteomyelitis: A cohort study in a tertiary care
hospital. BMC Infect Dis. 10(158)2010.PubMed/NCBI View Article : Google Scholar
|
21
|
Sobottke R, Röllinghoff M, Zarghooni K,
Zarghooni K, Schlüter-Brust K, Delank KS, Seifert H, Zweig T and
Eysel P: Spondylodiscitis in the elderly patient: Clinical mid-term
results and quality of life. Arch Orthop Trauma Surg.
130:1083–1091. 2010.PubMed/NCBI View Article : Google Scholar
|
22
|
Torda AJ, Gottlieb T and Bradbury R:
Pyogenic vertebral osteomyelitis: Analysis of 20 cases and review.
Clin Infect Dis. 20:320–328. 1995.PubMed/NCBI View Article : Google Scholar
|
23
|
Mylona E, Samarkos M, Kakalou E,
Fanourgiakis P and Skoutelis A: Pyogenic vertebral osteomyelitis: A
systematic review of clinical characteristics. Semin Arthritis
Rheu. 39:10–17. 2009.PubMed/NCBI View Article : Google Scholar
|
24
|
McHenry MC, Easley KA and Locker GA:
Vertebral osteomyelitis: Long-term outcome for 253 patients from 7
Cleveland-area hospitals. Clin Infect Dis. 34:1342–1350.
2002.PubMed/NCBI View
Article : Google Scholar
|
25
|
Cottle L and Riordan T: Infectious
spondylodiscitis. J Infect. 56:401–412. 2008.PubMed/NCBI View Article : Google Scholar
|
26
|
Varma R, Lander P and Assaf A: Imaging of
pyogenic infectious spondylodiskitis. Radiol Clin North Am.
39:203–213. 2001.PubMed/NCBI View Article : Google Scholar
|
27
|
An HS and Seldomridge JA: Spinal
infections: Diagnostic tests and imaging studies. Clin Orthop Relat
Res. 444:27–33. 2006.PubMed/NCBI View Article : Google Scholar
|
28
|
Love C and Palestro CJ: Nuclear medicine
imaging of bone infections. Clin Radiol. 71:632–646.
2016.PubMed/NCBI View Article : Google Scholar
|
29
|
Censullo A and Vijayan T: Using nuclear
medicine imaging wisely in diagnosing infectious diseases. Open
Forum Infect Dis. 4(ofx011)2017.PubMed/NCBI View Article : Google Scholar
|
30
|
Gasbarrini A, Boriani L, Nanni C,
Zamparini E, Rorato G, Ghermandi R, Salvadori C, Allegri V,
Bandiera S, Barbanti-Brodano G, et al: Spinal infection
multidisciplinary management project (SIMP): From diagnosis to
treatment guideline. Int J Immunopathol Pharmacol. 24 (Suppl
2):S95–S100. 2011.PubMed/NCBI View Article : Google Scholar
|
31
|
Pan A, Lorenzotti S and Zoncada A:
Registered and investigational drugs for the treatment of
methicillin-resistant Staphylococcus aureus infection.
Recent Pat Antiinfect Drug Discov. 3:10–33. 2008.PubMed/NCBI View Article : Google Scholar
|
32
|
Marino A, Stracquadanio S, Ceccarelli M,
Zagami A, Nunnari G and Cacopardo B: Oral fosfomycin formulation
for acute bacterial prostatitis; a new role for an old molecule: A
case report and brief literature review. World Acad Sci J.
4(26)2022.PubMed/NCBI View Article : Google Scholar
|
33
|
Marino A, Stracquadanio S, Campanella E,
Munafò A, Gussio M, Ceccarelli M, Bernardini R, Nunnari G and
Cacopardo B: Intravenous fosfomycin: A potential good partner for
cefiderocol. Clinical experience and considerations. Antibiotics
(Basel). 12(49)2022.PubMed/NCBI View Article : Google Scholar
|
34
|
Marino A, Stracquadanio S, Bellanca CM,
Augello E, Ceccarelli M, Cantarella G, Bernardini R, Nunnari G and
Cacopardo B: Oral fosfomycin formulation in bacterial prostatitis:
New role for an old molecule-brief literature review and clinical
considerations. Infect Dis Rep. 14:621–634. 2022.PubMed/NCBI View Article : Google Scholar
|
35
|
Poeppl W, Tobudic S, Lingscheid T,
Plasenzotti R, Kozakowski N, Georgopoulos A and Burgmann H:
Efficacy of fosfomycin in experimental osteomyelitis due to
methicillin-resistant ssylococcus aureus. Antimicrob Agents
Chemother. 55:931–933. 2011.PubMed/NCBI View Article : Google Scholar
|
36
|
Morata L and Soriano A: The role of
fosfomycin in osteoarticular infection. Rev Esp Quimioter. 32
(Suppl 1):S30–S36. 2019.PubMed/NCBI
|
37
|
Thabit AK, Fatani DF, Bamakhrama MS,
Barnawi OA, Basudan LO and Alhejaili SF: Antibiotic penetration
into bone and joints: An updated review. Int J Infect Dis.
81:128–136. 2019.PubMed/NCBI View Article : Google Scholar
|
38
|
Silber JS, Anderson DG, Vaccaro AR,
Anderson PA and McCormick P: NASS. Management of postprocedural
discitis. Spine J. 2:279–287. 2002.PubMed/NCBI View Article : Google Scholar
|
39
|
Chen WH, Jiang LS and Dai LY: Surgical
treatment of pyogenic vertebral osteomyelitis with spinal
instrumentation. Eur Spine J. 16:1307–1316. 2007.PubMed/NCBI View Article : Google Scholar
|